P
Prabin Thapa
Researcher at Mayo Clinic
Publications - 139
Citations - 5203
Prabin Thapa is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Cystectomy & Bladder cancer. The author has an hindex of 33, co-authored 117 publications receiving 4012 citations. Previous affiliations of Prabin Thapa include University of Rochester.
Papers
More filters
Journal ArticleDOI
High Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis
Keith D. Lindor,Kris V. Kowdley,Velimir A. Luketic,M. Edwyn Harrison,Timothy M. McCashland,Alex S. Befeler,Denise M. Harnois,Roberta A. Jorgensen,Jan Petz,Jill C. Keach,Jody Mooney,Carol Sargeant,Tamara Bernard,Debra King,Ellen Miceli,Jeff Schmoll,Tanya L. Hoskin,Prabin Thapa,Felicity Enders +18 more
TL;DR: Long‐term, high‐dose UDCA therapy is associated with improvement in serum liver tests in PSC but does not improve survival and was associated with higher rates of serious adverse events.
Journal ArticleDOI
Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer‐specific and all‐cause mortality
Sarah P. Psutka,Alonso Carrasco,Grant D. Schmit,Michael R. Moynagh,Stephen A. Boorjian,Igor Frank,Suzanne B. Stewart,Prabin Thapa,Robert F. Tarrell,John C. Cheville,Matthew K. Tollefson +10 more
TL;DR: The authors evaluated sarcopenia as a predictor of cancer‐specific survival (CSS) and overall survival (OS) among patients with urothelial cancer of the bladder undergoing radical cystectomy (RC).
Journal ArticleDOI
Outcome and undertreatment of mitral regurgitation: a community cohort study
Volha Dziadzko,Marie-Annick Clavel,Mikhail A. Dziadzko,Jose R. Medina-Inojosa,Hector I. Michelena,Joseph F. Maalouf,Vuyisile T. Nkomo,Prabin Thapa,Maurice Enriquez-Sarano +8 more
TL;DR: An observational cohort study to assess the clinical characteristics, outcomes, and degree of undertreatment of mitral regurgitation in a community setting in Olmsted County, USA found that patients with a low comorbidity burden combined with favourable characteristics such as left-ventricular ejection fraction of 50% or higher incurred excess mortality.
Journal ArticleDOI
Azathioprine Tolerability, efficacy, and predictors of benefit in neuromyelitis optica
Chiara Costanzi,Marcelo Matiello,Claudia F. Lucchinetti,Brian G. Weinshenker,Sean J. Pittock,Jay Mandrekar,Prabin Thapa,Andrew McKeon +7 more
TL;DR: This study provides Class IV evidence that azathioprine is effective for reducing relapse rates and improving EDSS and visual acuity scores in patients with NMO spectrum of disorders.
Journal ArticleDOI
Excess Mortality Associated with Functional Tricuspid Regurgitation Complicating Heart Failure with Reduced Ejection Fraction
Giovanni Benfari,Giovanni Benfari,Clemence Antoine,Wayne L. Miller,Prabin Thapa,Yan Topilsky,Andrea Rossi,Hector I. Michelena,Sorin V. Pislaru,Maurice Enriquez-Sarano +9 more
TL;DR: In this large cohort of patients with HFrEF, FTR was common and independently associated with PHTN, atrial-fibrillation and more severe heart failure presentation, and clinical trials should be directed at testing FTR treatment.